Federal Register / Vol. 77, No. 44 / Tuesday, March 6, 2012 / Notices 13347 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Epidemiology and Genetics of 

Chronic Disease. 

Date: March 28–29, 2012. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Julia Krushkal, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3148, 

MSC 7770, Bethesda, MD 20892, 301–435– 

1782, krushkalj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Epidermal, 

Lupus, and Wound Healing. 

Date: March 28–29, 2012. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Baljit S Moonga, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1777, moongabs@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 29, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5419 Filed 3–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Career Awards 

(2012/05). 

Date: March 26, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Democracy Two Building, Suite 

957, Bethesda, MD 20892, 301–496–4773, 

zhour@mail.nih.gov. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Point-of-Care 

Technologies Research Network (U54). 

Date: March 28–29, 2012. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: John K. Hayes, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Room 959, Bethesda, MD 20892, 

301–451–3398, hayesj@mail.nih.gov. 

Dated: February 29, 2012. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5425 Filed 3–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Ruth L. Kirschstein National 

Research Service Award (NRSA) Institutional 

Research Training Grants (Parent T32). 

Date: March 30, 2012. 

Time: 9:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Sujata Vijh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIAID/NIH/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616, 301– 

594–0985, vijhs@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 29, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5423 Filed 3–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIDCD. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute on Deafness and 

Other Communication Disorders, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of 

Scientific Counselors, NIDCD. 

Date: March 22, 2012. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate 

personal qualifications and 

performance, and competence of 

individual investigators. 

Place: National Institutes of Health, 5 

Research Court, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Andrew J. Griffith, 

Ph.D., MD, Director, Division of 

Intramural Research, National Institute 

on Deafness and Other Communication 

Disorders, 5 Research Court, Room 


pmangrum on DSK3VPTVN1PROD with NOTICES
13348 Federal Register / Vol. 77, No. 44 / Tuesday, March 6, 2012 / Notices 

1A13, Rockville, MD 20850, 301–496– 

1960, griffita@nidcd.nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the urgent need to meet timing 

limitations imposed by the intramural 

research review cycle. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nidcd.nih.gov/about/groups/bsc/, 

where an agenda and any additional 

information for the meeting will be 

posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: February 29, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5422 Filed 3–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Musculoskeletal and Vascular Sciences. 

Date: March 19, 2012. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Aftab A Ansari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, 301–237– 

9931, ansaria@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 28, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–5420 Filed 3–5–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Accreditation and Approval of 

Thionville Surveying Company, Inc., as 

a Commercial Gauger and Laboratory 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: Notice of accreditation and 

approval of Thionville Surveying 

Company, Inc., as a commercial gauger 

and laboratory. 

SUMMARY: Notice is hereby given that, 

pursuant to 19 CFR 151.12 and 19 CFR 

151.13, Thionville Surveying Company, 

Inc., 5440 Pepsi St, Harahan, LA 70123, 

has been approved to gauge and 

accredited to test petroleum and 

petroleum products, organic chemicals 

and vegetable oils for customs purposes, 

in accordance with the provisions of 19 

CFR 151.12 and 19 CFR 151.13. Anyone 

wishing to employ this entity to conduct 

laboratory analyses and gauger services 

should request and receive written 

assurances from the entity that it is 

accredited or approved by the U.S. 

Customs and Border Protection to 

conduct the specific test or gauger 

service requested. Alternatively, 

inquires regarding the specific test or 

gauger service this entity is accredited 

or approved to perform may be directed 

to the U.S. Customs and Border 

Protection by calling (202) 344–1060. 

The inquiry may also be sent to 

cbp.labhq@dhs.gov. Please reference the 

Web site listed below for a complete 

listing of CBP approved gaugers and 

accredited laboratories. http://cbp.gov/ 

linkhandler/cgov/trade/automated/ 

labs_scientific_svcs/ 

commercial_gaugers/gaulist.ctt/ 

gaulist.pdf 

DATES: The accreditation and approval 

of Thionville Surveying Company, Inc., 

as commercial gauger and laboratory 

became effective on June 22, 2011. The 

next triennial inspection date will be 

scheduled for June 2014. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan McGrath, Laboratories and 

Scientific Services, U.S. Customs and 

Border Protection, 1300 Pennsylvania 

Avenue NW., Suite 1500N, Washington, 

DC 20229, 202–344–1060. 

Dated: February 28, 2012. 

Ira S. Reese, 

Executive Director, Laboratories and 

Scientific Services. 

[FR Doc. 2012–5351 Filed 3–5–12; 8:45 am] 

BILLING CODE 9111–14–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Approval of VIP Chemical, Inc., As a 

Commercial Gauger 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: Notice of approval of VIP 

Chemical, Inc., as a commercial gauger. 

SUMMARY: Notice is hereby given that, 

pursuant to 19 CFR 151.13, VIP 

Chemical, Inc., 4026 FM 1694, 

Robstown, TX 78310, has been 

approved to gauge petroleum, petroleum 

products, organic chemicals and 

vegetable oils for customs purposes, in 

accordance with the provisions of 19 

CFR 151.13. Anyone wishing to employ 

this entity to conduct gauger services 

should request and receive written 

assurances from the entity that it is 

approved by the U.S. Customs and 

Border Protection to conduct the 

specific gauger service requested. 

Alternatively, inquires regarding the 

specific gauger service this entity is 

approved to perform may be directed to 

the U.S. Customs and Border Protection 

by calling (202) 344–1060. The inquiry 

may also be sent to cbp.labhq@dhs.gov. 

Please reference the Web site listed 

below for a complete listing of CBP 

approved gaugers and accredited 

laboratories. 

http://cbp.gov/linkhandler/cgov/

trade/automated/labs_scientific_svcs/

commercial_gaugers/gaulist.ctt/gaulist.

pdf 

DATES: The approval of VIP Chemical, 

Inc., as commercial gauger became 

effective on June 16, 2011. The next 

triennial inspection date will be 

scheduled for June 2014. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan McGrath, Laboratories and 

Scientific Services, U.S. Customs and 

Border Protection, 1300 Pennsylvania 

Avenue NW., Suite 1500N, Washington, 

DC 20229, 202–344–1060. 


pmangrum on DSK3VPTVN1PROD with NOTICES